WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Todd Astor, MD
Mediar Therapeutics
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
69 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Wisper Site in Buenos Aires, Argentina
Buenos Aires, Argentina
Recruiting - Wisper Site in Cordoba, Argentina
Córdoba, Argentina
Recruiting - Wisper Site in Mendoza, Argentina
Mendoza, Argentina
Recruiting - Wisper Site in Rosario, Argentina
Rosario, Argentina
Recruiting - Wisper Site in San Miguel de Tucumán, Argentina
San Miguel de Tucumán, Argentina
Recruiting - Wisper Site in Santa Fe, Argentina
Santa Fe, Argentina
Recruiting - Wisper Site in Santa Fe, Argentina
Santa Fe, Argentina
Recruiting
- Wisper Site in Greenslopes, Australia
Greenslopes, Australia
Recruiting - Wisper Site in Melbourne, Australia
Melbourne, Australia
Recruiting - Wisper Site in Midland, Australia
Midland, Australia
Recruiting - Wisper Site in Westmead, Australia
Westmead, Australia
Recruiting
- Wisper Site in Brussels, Belgium
Brussels, Belgium
Recruiting - Wisper Site in Edegem, Belgium
Edegem, Belgium
Recruiting
- Wisper Site in Belo Horizonte, Brazil
Belo Horizonte, Brazil
Recruiting - Wisper Site in Curitiba, Brazil
Curitiba, Brazil
Recruiting - Wisper Site in Passo Fundo, Brazil
Passo Fundo, Brazil
Recruiting - Wisper Site in Porto Alegre, Brazil
Porto Alegre, Brazil
Recruiting - Wisper Site in Porto Alegre, Brazil
Porto Alegre, Brazil
Recruiting - Wisp Site in São Bernardo Do Campo, Brazil
São Bernardo do Campo, Brazil
Recruiting - Wisper Site in Sao Paulo, Brazil
São Paulo, Brazil
Recruiting
- Wisper Site in Calgary, Alberta
Calgary, Alberta, Canada
Recruiting - Wisper Site in Ajax, on
Ajax, Ontario, Canada
Recruiting - Wisper Site in Trois-Rivières, Quebec
Trois-Rivières, Quebec, Canada
Recruiting
- Wisper Site in Split
Split, Croatia
Recruiting
- Wisper Site in Nantes, France
Nantes, France
Recruiting - Wisper Site in Nice, France
Nice, France
Recruiting - Wisper Site in Paris, France
Paris, France
Recruiting - Wisper Site in Rennes, France
Rennes, France
Recruiting
- Wisper Site in Abbotstown, Ireland
Abbotstown, Ireland
Recruiting - Wisper Site in Drogheda, Ireland
Drogheda, Ireland
Recruiting - Wisper Site in Dublin, Ireland
Dublin, Ireland
Recruiting - Wisper Site in Letterkenny, Ireland
Letterkenny, Ireland
Recruiting
- Wisper Site in Nieuwegein, Netherlands
Nieuwegein, Netherlands
Recruiting
- Wisper Site in Barcelona, Spain
Barcelona, Spain
Recruiting - Wisper Site in Barcelona, Spain
Barcelona, Spain
Recruiting - Wisper Site in Lugo, Spain
Lugo, Spain
Recruiting - Wisper Site in Madrid, Spain
Madrid, Spain
Recruiting - Wisper Site in Madrid, Spain 2
Madrid, Spain
Recruiting - Wisper Site in Santander, Spain
Santander, Spain
Recruiting
- Wisper Site in Birmingham, Uk
Birmingham, United Kingdom
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 May 2025
- Primary completion
- 31 Aug 2027
- Completion
- 31 Aug 2027
- Last update posted
- 12 Jun 2026
- Registered enrollment
- 164
- Registry id
- NCT06967805
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.